TrivarX Ltd: March 2025 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: IRB approval for trial with US Dept of Veterans Affairs
TrivarX Ltd: Letter to Shareholders & Notice of GM & Proxy Form
TrivarX Ltd: Change in substantial holding
TrivarX Ltd: Cleansing Notice
TrivarX Ltd: Application for quotation of securities - TRI
TrivarX Ltd: Proposed issue of securities - TRI
TrivarX Ltd: Cleansing Notice
TrivarX Ltd: Application for quotation of securities - TRI
TrivarX Ltd: Proposed issue of securities - TRI
TrivarX Ltd: Proposed issue of securities - TRI
TrivarX Ltd: TrivarX Receives Firm Commitments to Raise $2.25 million
TrivarX Ltd: Trading Halt
TrivarX Ltd: Trial with US Department of Veterans Affairs
TrivarX Ltd: Appendix 4D & Half-Year Financial Report to 31 December 2024
TrivarX Ltd: December 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Positive engagement with FDA following meeting for MEB-001
TrivarX Ltd: Cleansing Notice
TrivarX Ltd: Application for quotation of securities - TRI
TrivarX Ltd: Proposed issue of securities - TRI